Harvard Bioscience Inc. (NASDAQ: HBIO)
$2.2500
+0.0900 ( +2.74% ) 111.1K
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
Market Data
Open
$2.2500
Previous close
$2.1600
Volume
111.1K
Market cap
$96.63M
Day range
$2.1600 - $2.2400
52 week range
$1.9900 - $5.5600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 91 | Nov 08, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
10-q | Quarterly Reports | 94 | Aug 08, 2024 |
8-k | 8K-related | 15 | Aug 08, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | May 23, 2024 |
4 | Insider transactions | 1 | May 23, 2024 |
4 | Insider transactions | 1 | May 23, 2024 |
4 | Insider transactions | 1 | May 23, 2024 |